Ketoprofen ext-rel Caps Rx
Generic Name and Formulations:
Ketoprofen 200mg; ext rel; pH-dependent coated pellets in caps.
Various generic manufacturers
Indications for Ketoprofen ext-rel Caps:
Osteoarthritis. Rheumatoid arthritis.
Aspirin allergy. Late pregnancy. Coronary artery bypass graft surgery.
Advanced renal disease: not recommended. Acute pain. Renal or hepatic dysfunction. Edema. Hypertension. Cardiac failure. History of upper GI disease. Bleeding disorders. Hypoalbuminemia. Monitor blood, hepatic, renal, and ocular function in chronic use. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended.
Avoid salicylates, probenecid. Renal toxicity potentiated with diuretics. Monitor oral anticoagulants. May increase toxicity of methotrexate. May increase serum lithium levels.
NSAID (propionic acid deriv.).
GI bleeding, peptic ulcer, peripheral edema, dyspepsia, headache, dizziness, drowsiness, nausea, abdominal pain, diarrhea, constipation, flatulence, rash (discontinue if occurs), tinnitus, visual disturbances, GI or CNS disturbances, nephrotoxicity, jaundice. See literature re: risk of cardiovascular events.
Formerly known under the brand name Oruvail.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|